C. López Galíndez-rekin lankidetzan egindako argitalpenak (7)

2020

  1. Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure

    Scientific Reports, Vol. 10, Núm. 1

2015

  1. HIV-1 dual infected LTNP-EC patients developed an unexpected antibody cross-neutralizing activity

    PLoS ONE, Vol. 10, Núm. 8

2012

  1. Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller

    PLoS ONE, Vol. 7, Núm. 2

2007

  1. Genetic changes associated with distinct patterns of HIV type 1 persistence in chronically infected cell lines

    AIDS Research and Human Retroviruses, Vol. 23, Núm. 2, pp. 251-260

2003

  1. Genetic analysis of culture-negative UNAIDS subtype C samples

    AIDS Research and Human Retroviruses, Vol. 19, Núm. 1, pp. 49-55

2001

  1. Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein

    Journal of Virology, Vol. 75, Núm. 20, pp. 9644-9653

1999

  1. Second-site reversion of a human immunodeficiency virus type 1 reverse transcriptase mutant that restores enzyme function and replication capacity

    Journal of Virology, Vol. 73, Núm. 8, pp. 6293-6298